ArticleScientific reports2017

Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.

Natalie E Stevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.